[溴隐亭，前列腺腺瘤和癌的一种新治疗原则。依据、可能性、局限性] - Suppr | 超能文献

[Bromocriptine, a new therapeutic principle in prostatic adenoma and carcinoma. Basis, possibilities, limits].

作者信息

Jacobi G H, Altwein J E

出版信息

Dtsch Med Wochenschr. 1978 May 12;103(19):827-33. doi: 10.1055/s-0028-1104520.

DOI:10.1055/s-0028-1104520

PMID:77217

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Bromocriptine, a new therapeutic principle in prostatic adenoma and carcinoma. Basis, possibilities, limits].[溴隐亭，前列腺腺瘤和癌的一种新治疗原则。依据、可能性、局限性]

Dtsch Med Wochenschr. 1978 May 12;103(19):827-33. doi: 10.1055/s-0028-1104520.

2

[Bromocryptin, a new therapeutic principle in adenoma and carcinoma of the prostate. Presuppositions, possibilities and limitations].[溴隐亭，前列腺腺瘤和癌的一种新治疗原则。前提、可能性与局限性]

Minerva Urol. 1980 Jul-Sep;32(3):167-73.

3

The effect of ergobromocriptine on serum testosterone and prolactin levels in patients with carcinoma of the prostate.麦角溴隐亭对前列腺癌患者血清睾酮和催乳素水平的影响。

Int Urol Nephrol. 1986;18(1):71-4. doi: 10.1007/BF02082651.

4

[Treatment of prostatic carcinoma with phostrolin and bromocriptine while monitoring serum concentrations of testosterone and prolactin].[使用磷雌酚和溴隐亭治疗前列腺癌并监测血清睾酮和催乳素浓度]

Pol Tyg Lek. 1980 Mar 10;35(10):359-62.

5

Clinical trial of 2-bromo-alpha-ergocryptine (NSC-169774) in human prostatic cancer.

Cancer Chemother Rep. 1975 Jan-Feb;59(1):209-13.

6

[Prolactin and cancer of the prostate. IV. Prolactin inhibition in the treatment of prostatic cancer].[催乳素与前列腺癌。IV. 催乳素抑制在前列腺癌治疗中的应用]

Arch Esp Urol. 1982 Sep-Oct;35(5):312-25.

7

[Prolactin and prostatic cancer. Modification of testosterone serum levels in estrogen-induced hyperprolactinemia by bromocriptine].

Actas Urol Esp. 1983 Jul-Aug;7(4):289-94.

8

The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.抗雌激素、抗雄激素及催乳素抑制剂2-溴-α-麦角隐亭对人良性前列腺增生间质组织的作用。体视学数据与血浆激素的相关性。

Invest Urol. 1981 Jan;18(4):308-12.

9

[Bromocriptine and prostatic carcinoma: testosterone metabolism in relation to tumor grading (author's transl)].[溴隐亭与前列腺癌：睾酮代谢与肿瘤分级的关系（作者译）]

Urologe A. 1979 Mar;18(2):91-8.

10

The serum levels of testosterone and prolactin in patients with prostatic carcinoma treated with various doses of Fostrolin and bromocriptin.接受不同剂量福司曲林和溴隐亭治疗的前列腺癌患者的睾酮和催乳素血清水平。

Int Urol Nephrol. 1982;14(1):51-6. doi: 10.1007/BF02082383.

引用本文的文献

1

The serum levels of testosterone and prolactin in patients with prostatic carcinoma treated with various doses of Fostrolin and bromocriptin.接受不同剂量福司曲林和溴隐亭治疗的前列腺癌患者的睾酮和催乳素血清水平。

Int Urol Nephrol. 1982;14(1):51-6. doi: 10.1007/BF02082383.

2

Alterations of peripheral testosterone matabolism after induced hypoprolactinemia in patients with prostatic carcinoma.前列腺癌患者诱导性低催乳素血症后外周睾酮代谢的改变。

Klin Wochenschr. 1979 Jan 1;57(1):49-51. doi: 10.1007/BF01476982.